0001835830-24-000093.txt : 20240906 0001835830-24-000093.hdr.sgml : 20240906 20240906201326 ACCESSION NUMBER: 0001835830-24-000093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240906 FILED AS OF DATE: 20240906 DATE AS OF CHANGE: 20240906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Whalen Amanda CENTRAL INDEX KEY: 0001991131 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41806 FILM NUMBER: 241285646 MAIL ADDRESS: STREET 1: KLAVIYO, INC. STREET 2: 125 SUMMER STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Klaviyo, Inc. CENTRAL INDEX KEY: 0001835830 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET, FLOOR 6 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 800-338-1744 MAIL ADDRESS: STREET 1: 125 SUMMER STREET, FLOOR 6 CITY: BOSTON STATE: MA ZIP: 02110 4 1 wk-form4_1725668000.xml FORM 4 X0508 4 2024-09-06 0 0001835830 Klaviyo, Inc. KVYO 0001991131 Whalen Amanda C/O KLAVIYO, INC. 125 SUMMER STREET, 6TH FLOOR BOSTON MA 02110 0 1 0 0 Chief Financial Officer 1 Series A Common Stock 2024-09-06 4 C 0 10000 A 432813 D Series A Common Stock 2024-09-06 4 S 0 9800 29.73 D 423013 D Series A Common Stock 2024-09-06 4 S 0 200 29.39 D 422813 D Series B Common Stock 2024-09-06 4 C 0 10000 0 D Series A Common Stock 10000 615118 D These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023. Each share of Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), of the Issuer, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.47 to $30.46 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.35 to $29.42 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Consists of (i) 41,911 shares of Series A Common Stock and (ii) 380,902 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Consists of (i) 184,909 shares of Series B Common Stock and (ii) 430,209 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. /s/ Landon Edmond, Attorney-in-Fact 2024-09-06